Comparison 30. Glycopyrrolate vs control.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
30.1 Women with hypotension requiring intervention	2	142	Risk Ratio (M‐H, Random, 95% CI)	0.63 [0.21, 1.91]
30.2 Women with hypertension requiring intervention	1	93	Risk Ratio (M‐H, Random, 95% CI)	2.67 [1.31, 5.43]
30.3 Women with bradycardia	1	93	Risk Ratio (M‐H, Random, 95% CI)	0.21 [0.01, 4.32]
30.4 Women with nausea and/or vomiting	2		Risk Ratio (M‐H, Random, 95% CI)	Subtotals only
30.4.1 Nausea or vomiting	1	93	Risk Ratio (M‐H, Random, 95% CI)	2.49 [0.69, 9.04]
30.4.2 Nausea	1	49	Risk Ratio (M‐H, Random, 95% CI)	0.61 [0.36, 1.06]
30.4.3 Vomiting	1	49	Risk Ratio (M‐H, Random, 95% CI)	0.52 [0.10, 2.59]
30.5 Neonates with Apgar score < 8 at 5 min	2	142	Risk Ratio (M‐H, Random, 95% CI)	Not estimable